首页 | 本学科首页   官方微博 | 高级检索  
   检索      

药物作用靶点研究最新进展
引用本文:江振洲,杨婷婷,李晓骄阳,张陆勇.药物作用靶点研究最新进展[J].微生物学杂志,2014,38(3).
作者姓名:江振洲  杨婷婷  李晓骄阳  张陆勇
作者单位:中国药科大学江苏省新药筛选中心,江苏 南京 210009;中国药科大学江苏省药效研究与评价服务中心,江苏 南京 210009,中国药科大学江苏省新药筛选中心,江苏 南京 210009;中国药科大学江苏省药效研究与评价服务中心,江苏 南京 210010,中国药科大学江苏省新药筛选中心,江苏 南京 210009,中国药科大学江苏省新药筛选中心,江苏 南京 210009;中国药科大学药物质量与安全预警教育部重点实验室,江苏 南京 210009
摘    要:通过对我国学者近2年在国内外发表的相关论文进行检索和整理,分类综述针对神经退行性疾病(如阿尔茨海默病、帕金森病等)、心血管疾病(如高血压、心律失常、心衰、冠心病、心肌梗死、动脉粥样硬化等)、脑血管疾病、代谢类疾病(如肥胖症、血脂异常、脂肪肝、糖尿病等)、感染性疾病(如艾滋病、流感、结核病等)、恶性肿瘤、自身免疫性疾病等多种疾病的药物作用靶点研究最新进展。

关 键 词:药物靶点  神经退行性疾病  心血管疾病  脑血管疾病  代谢类疾病  感染性疾病  恶性肿瘤  自身免疫性疾病

The Latest Progress in Research of Drug Target
JIANG Zhenzhou,YANG Tingting,LI Xiaojiaoyang and ZHANG Luyong.The Latest Progress in Research of Drug Target[J].Journal of Microbiology,2014,38(3).
Authors:JIANG Zhenzhou  YANG Tingting  LI Xiaojiaoyang and ZHANG Luyong
Institution:iangsu Center for Drug Screening, China Pharmaceutical University, Nanjing 210009, China;Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, Nanjing 210009, China,iangsu Center for Drug Screening, China Pharmaceutical University, Nanjing 210009, China;Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, Nanjing 210010, China,iangsu Center for Drug Screening, China Pharmaceutical University, Nanjing 210009, China; and iangsu Center for Drug Screening, China Pharmaceutical University, Nanjing 210009, China;Key Laboratory of Drug Quality Control and Pharmacovigilance of Ministry of Education, China Pharmaceutical University, Nanjing 210009, China
Abstract:Through the retrieving, analyzing and summerizing of the related papers published by Chinese scholars both at home and abroad in the past two years, the latest progress in research of drug targets for a variety of diseases, including neurodegenerative diseases (Alzheimer''s disease, Parkinson''s disease,etc.), cardiovascular diseases (hypertension, arrhythmia, heart failure, coronary heart disease, myocardial infarction, atherosclerosis,etc.), cerebrovascular diseases, metabolic diseases (obesity, dyslipidemia, fatty liver, diabetes, etc.), infectious diseases (AIDS, influenza, tuberculosis, etc.), malignancies as well as autoimmune diseases, were classifiedly reviewed.
Keywords:drug target  neurodegenerative disease  cardiovascular disease  cerebrovascular disease  metabolic disease  infectious disease  malignancy  autoimmune disease
点击此处可从《微生物学杂志》浏览原始摘要信息
点击此处可从《微生物学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号